Characterization and survival of patients with Hodgkin lymphoma. A 7-Year single-center study

Original Research

Published

2022-08-06

How to Cite

Quinte Guaiña, F. V., Terán Terán, R. N., & Espinoza de los Monteros, R. (2022). Characterization and survival of patients with Hodgkin lymphoma. A 7-Year single-center study: Original Research. Oncology Journal (Ecuador), 32(2), 141–156. https://doi.org/10.33821/630

Issue

Section

Original Articles

Authors

  • Fanny Viviana Quinte Guaiña Postgrado de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, https://orcid.org/0000-0002-8884-6136
  • Rosa Nohemí Terán Terán Postgrado de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito
  • Rommel Espinoza de los Monteros Unidad de Oncología y Hematología, Hospital de Especialidades Carlos Andrade Marín, Instituto Ecuatoriano de Seguridad Social, Quito

DOI:

https://doi.org/10.33821/630

Keywords:

Hodgkin Disease, Lymphoma AIDS-Related, /mortality, Hospital Mortality, Mortality Registries, SURVIVAL ANALYSIS

Abstract

Introduction:  Hodgkin's Lymphoma (HL) is a rare hematological neoplasm where neoplastic cells form a minority of the tumor and are surrounded by a reactive inflammatory medium that includes lymphocytes eosinophils, neutrophils, histiocytes, and plasma cells. The objective of the present study was to describe a population with this pathology and its survival in 7 years of follow-up.

Methodology: This longitudinal study was carried out at the Carlos Andrade Marín Hospital, in Quito, Ecuador, from 2013-2019, with a non-probabilistic sample of patients with HL. Demographic, clinical, laboratory variables, Ann Arbor classification, histological classification, treatment and response, mortality, and survival time were recorded. Descriptive statistics are used; bivariate and survival analysis.

Downloads

Download data is not yet available.

Most read articles by the same author(s)